Results 11 to 20 of about 5,721 (196)
The Effect of Nebivolol on Subarachnoid Hemorrhage-induced Vasospasm in the Rabbit [PDF]
Bagcilar Medical Bulletin, 2019 Objective:This study aimed to investigate the vasorelaxation effect of nebivolol on vasospasm in the rabbit model of subarachnoid hemorrhage (SAH).Method:Single-hemorrhage model in the rabbit SAH was employed. SAH was induced in animals by cisterna manga
İlker Güleç, Ali Nail İzgi
doaj +2 more sources
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
Vascular Health and Risk Management, 2006 Robert WeissAndroscoggin Cardiology Associates, Auburn, ME, USAAbstract: Nebivolol is a novel beta1-blocker with a greater degree of selectivity for beta1- adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating ...
Robert Weiss
doaj +1 more source
Nebivolol-induced hepatoxicity: a case report
European Journal of Case Reports in Internal MedicineNebivolol is a third-generation beta-blocker known for its high selectivity for beta-1 adrenergic receptors and its unique ability to induce vasodilation via nitric oxide (NO) release.
Lynn Srour +3 more
doaj +3 more sources
The Effect of Nebivolol on Acute Renal Injury Developed After Myocardial Ischemia: A Preclinical Study [PDF]
Haseki Tıp Bülteni, 2018 Aim:During reperfusion of myocardial ischemia, damage can also be seen in the kidneys. Although many studies have been conducted on the underlying mechanisms, the basic mechanism of this interaction is still unknown.
Güldem Mercanoğlu +3 more
doaj +2 more sources
Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
The Scientific World Journal, 2002 Nebivolol is a new selective beta 1-adrenoceptor antagonist with nitric oxide (NO)–releasing properties. In the present study we have analyzed whether nebivolol affects the development of the arterial hypertension that follows the chronic inhibition of ...
L.A. Fortepiani +3 more
doaj +2 more sources
A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
Vascular Health and Risk Management, 2008 John CockcroftWales Heart Research Institute, University Hospital Heath Park, Cardiff, UKAbstract: Nebivolol is a third generation beta-blocker, which can be distinguished from other beta-blockers by its hemodynamic profile.
John Cockcroft
doaj +1 more source
Vascular Health and Risk Management, 2008 André C Schmidt1, Burkhard Flick1, Elke Jahn2, Peter Bramlage31Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, Germany; 2Berlin-Chemie AG, Clinical Research and Medical ...
André C Schmidt +3 more
doaj +1 more source
Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model [PDF]
Frontiers in Physiology, 2017 Background: Hypertrophic cardiomyopathy (HCM) patients often present with diastolic dysfunction and a normal to supranormal systolic function. To counteract this hypercontractility, guideline therapies advocate treatment with beta-adrenoceptor and Ca2 ...
Sabrina Stücker +7 more
doaj +2 more sources
University Heart Journal, 1970 Nebivolol is a vasodilating β-blocker, which can be distinguished from other β-blockers by its haemodynamic profile. It combines β-adrenergic blocking activity with a vasodilating effect mediated by the endothelial Larginine nitric oxide (NO) pathway. The blood pressure lowering effect of nebivolol is linked to a reduction in peripheral resistance and ...
Md Atiqur Rahman +6 more
openaire +3 more sources
Nebivolol induced hyperkalemia: case report
Acta Clinica Croatica, 2016 In this article, we document a conclusive case of nebivolol-induced hyperkalemia for the first time in the known medical literature. Hyperkalemia is associated with serious conditions such as cardiac arrhythmias and sudden cardiac death.
Karmela Altabas +2 more
doaj +3 more sources